Search

Our findings indicate that surgical site infections can be reduced effectively over the long term with a hospital-wide implementation of multidisciplinary best practices.

… Thursday, December 13, 2018 Implementation of a multidisciplinary care bundle composed of 13 perioperative components has significantly decreased the rate of surgical site infections (SSIs) among patients undergoing colorectal cancer surgery at Memorial Sloan Kettering Cancer Center, according to our

The Specialized Programs of Research Excellence (SPORE) grant will fund efforts focusing on the development of new treatments.

… Tuesday, September 7, 2021 Memorial Sloan Kettering Cancer Center has received a major grant from the US National Institutes of Health (NIH) to conduct research related to leukemia . It is the sixth grant of this type to be received by MSK investigators. It is referred to as a SPORE grant, for Specialized

Pediatric surgeon J. Ted Gerstle, MD, FACS, FRCS, has been named the new Chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK).

… Thursday, July 12, 2018 Pediatric surgeon J. Ted Gerstle, MD, FACS, FRCS , has been named the new Chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician and leader, Dr. Gerstle most recently served as Director of

The immunotherapy drug nivolumab is now approved for patients whose Hodgkin lymphoma has failed other treatments.

… Thursday, May 19, 2016 https://www.youtube.com/watch?v=lrB1gjztQSk The immunotherapy drug nivolumab is giving hope to Hodgkin lymphoma patients like Ariella after standard treatments don’t work. Video courtesy Cancer Research Institute. Summary Patients with Hodgkin lymphoma whose disease returns after

Chief of the Melanoma Service Michael Postow, MD, Medical Oncologist Nitya Raj, MD, and Assistant Attending Triparna Sen, PhD were included on this year’s list.

… Thursday, October 15, 2020 Memorial Sloan Kettering (MSK) is proud to announce that Chief of the Melanoma Service https://www.mskcc.org/cancer-care/doctors/michael-postow Michael Postow, MD , Medical Oncologist  Nitya Raj, MD , and Assistant Attending Triparna Sen, PhD, are included in the 40 Under 40

New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer.

… Monday, October 26, 2020 Summary MSK investigators uncover new findings about the relationship between clonal hematopoiesis in cancer patients and the risk of later developing a treatment-related blood cancer. In recent years, improvements in cancer therapy have led to a significant increase in cancer

Read advice from an MSK clinical psychologist about how caregivers of people with cancer can best manage their emotions and life responsibilities.

… Tuesday, February 27, 2024 For family caregivers, one of the major stresses is  advance care planning  — the process of talking about and documenting goals for future healthcare. Since 2012, the Counseling Center at Memorial Sloan Kettering Cancer Center (MSK) has provided individual and family support

Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.

… Tuesday, October 1, 2013 Summary Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of. VIDEO | 00:14 The Social Behavior of Bacteria Offers New Ideas for Antimicrobial Drug Design Video Details This movie clip shows Pseudomonas

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

… Wednesday, December 19, 2012 Summary Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs. Metastasis , the process by which some tumors spread from their site of origin to other body

After an extensive nationwide search, Memorial Sloan Kettering Cancer Center (MSK) announced today that Lisa M. DeAngelis has been named Physician-in-Chief and Chief Medical Officer. A leading expert in brain cancer, Dr. DeAngelis previously served as Chair of the Department of Neurology and was co-founder of MSK’s Brain Tumor Center during her 30-plus-year tenure at the institution.

… Tuesday, September 10, 2019 Lisa M. DeAngelis Has Been Named Physician-in-Chief and Chief Medical Officer of MSK Lisa M. DeAngelis Has Been Named Physician-in-Chief and Chief Medical Officer of MSK After an extensive nationwide search, Memorial Sloan Kettering Cancer Center (MSK) announced today that